Post-vaccination T cell immunity to omicron

Post-vaccination T cell immunity to omicron

In late 2021, the omicron variant of SARS Coronavirus 2 (SARS-CoV-2) emerged and replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against omicron has been challenging to estimate in clinical studies or is not available for all vaccines or populations of interest. T c...

Full description

Bibliographic Details
Main Authors:	Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, Naor Bar-Zeev, Luka Čičin-Šain, Melissa M. Higdon, Maria Deloria-Knoll
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 omicron T cell COVID-19 vaccine
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.944713/full

Similar Items

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
by: Henning Jacobsen, et al.
Published: (2022-10-01)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
by: Maeva Katzmarzyk, et al.
Published: (2023-11-01)

Učinci i sigurnosni profil dječjih cjepiva u svijetlu bioloških temelja imunološke reakcije
by: Luka Čičin-Šain
Published: (2023-01-01)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
by: Mario Alberto Ynga-Durand, et al.
Published: (2019-10-01)

Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
by: Henning Jacobsen, et al.
Published: (2022-05-01)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
by: Kristin Metzdorf, et al.
Published: (2023-01-01)

IT education strategy oriented to the alignment between business and information systems
by: Marko Čičin-Šain, et al.
Published: (2013-12-01)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
by: Ioannis Sitaras, et al.
Published: (2022-11-01)

NOVI PRISTUP U ODREĐENJU DOBITI STALNE POSLOVNE JEDINICE – PRISTUP OECD-A TE IMPLIKACIJE ZA HRVATSKO POREZNO PRAVO
by: Nevia Čičin-Šain
Published: (2016-01-01)

Reflections on the Structure of Croatian Measures for Limiting the Deductibility of Financial Expenses: Efficiency vs Compatibility
by: Nevia Čičin-Šain
Published: (2016-12-01)

Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
by: Maeva Katzmarzyk, et al.
Published: (2024-10-01)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
by: Yuntao Zhang, et al.
Published: (2022-07-01)

Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
by: Henning Jacobsen, et al.
Published: (2023-10-01)

A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
by: Kristin Metzdorf, et al.
Published: (2024-07-01)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
by: Wanting Li, et al.
Published: (2023-08-01)

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants
by: Yi Wu, et al.
Published: (2025-02-01)

Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
by: Karan Thakkar, et al.
Published: (2023-12-01)

Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
by: Karan Thakkar, et al.
Published: (2023-12-01)

The importance of booster vaccination in the context of Omicron wave
by: Zichun Wei, et al.
Published: (2022-09-01)

UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene
by: M. Zeeshan Chaudhry, et al.
Published: (2017-07-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01)

Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults
by: Suad Hannawi, et al.
Published: (2024-09-01)

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
by: Gaurav Joshi, et al.
Published: (2022-01-01)

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
by: Yousra Kherabi, et al.
Published: (2022-09-01)

Dynamic monitoring of viral gene expression reveals rapid antiviral effects of CD8 T cells recognizing the HCMV-pp65 antigen
by: Fawad Khan, et al.
Published: (2024-07-01)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
by: Ye-Fan Hu, et al.
Published: (2022-02-01)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
by: Eugen Ovcar, et al.
Published: (2023-08-01)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
by: María I. Zapata-Cardona, et al.
Published: (2022-12-01)

Effectiveness of COVID-19 Vaccines over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population
by: Yiyi Xu, et al.
Published: (2022-12-01)

Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China
by: Kongbo Zhu, et al.
Published: (2023-08-01)

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
by: Maren Schubert, et al.
Published: (2022-03-01)

Omicron strain: nature, risk evaluation, and treatment approach
by: Faeze Baniyaghoobi, et al.
Published: (2022-10-01)

Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant
by: Jiajun Wu, et al.
Published: (2022-07-01)

The emergence of new variants and sub-variants of SARS-CoV-2 and the effectiveness of vaccines
by: Emad Behboudi, et al.
Published: (2023-02-01)

Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections
by: Gabriel Innocenti, et al.
Published: (2024-08-01)

The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children
by: Djatnika Setiabudi, et al.
Published: (2022-08-01)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
by: Daniele Lapa, et al.
Published: (2022-05-01)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
by: Marta C. Nunes, et al.
Published: (2022-03-01)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
by: Yudi Xie, et al.
Published: (2022-09-01)

SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes
by: Mario Ynga-Durand, et al.
Published: (2022-06-01)